|
|
40
|
|
|
A7513
|
|
|
SANDOSTATIN LAR 20MG INJ (NVS/COL) OCTREOTIDE
|
|
|
OCTREOTIDE
|
|
|
SANDOSTATIN LAR
|
|
|
20MG VIAL
|
|
|
BQ
|
|
|
3,860.02
|
|
|
3,860.02
|
|
|
20MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
9292
|
|
|
OTHER THERAPEUTIC AGENTS
|
|
|
|
|
|
IV
|
|
|
6
|
|
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|